newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics Announces $8.5 Million in Equity Financings

BOSTON, April 11, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO) (the "Company"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial